Scarica l'app Stockscreener
0.3718
6.02%
0.0211
Jupiter Neurosciences Inc Borsa (JUNS) Ultime notizie
Buyback Watch: Can ACDC expand its profit margins2026 Catalysts & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Aug Patterns: Is Jupiter Neurosciences Inc benefiting from interest rate changesShort Setup & Long-Term Safe Investment Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
If You Invested $1,000 in JUPITER NEUROSCIENCES, INC. (JUNS) - Stock Titan
Will Jupiter Neurosciences Inc benefit from geopolitical trendsMarket Risk Report & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Jupiter Neurosciences, Inc.: Fundamental Analysis and Financial Ratings | JUNS | US48208B2034 - marketscreener.com
JUNS Forecast, Price Target & Analyst Ratings | JUPITER NEUROSCIENCES INC (NASDAQ:JUNS) - ChartMill
CEO Moves: Is Jupiter Neurosciences Inc benefiting from interest rate changesWeekly Profit Recap & Fast Gain Stock Tips - baoquankhu1.vn
Market Overview: Can Jupiter Neurosciences Inc. reach all time highs this yearGap Up & Scalable Portfolio Growth Methods - baoquankhu1.vn
Trading Action: Is Jupiter Neurosciences Inc forming a double bottomMarket Movers & Weekly High Return Forecasts - baoquankhu1.vn
Bull Bear: What is the earnings history of Jupiter Neurosciences IncTrend Reversal & Technical Buy Zone Confirmations - baoquankhu1.vn
Momentum Shift: How do insiders feel about Jupiter Neurosciences IncJuly 2025 PostEarnings & Weekly Breakout Watchlists - baoquankhu1.vn
Buyback Watch: Will Jupiter Neurosciences Inc face regulatory challengesJuly 2025 Big Picture & Daily Profit Focused Screening - baoquankhu1.vn
Aug Rallies: Can Jupiter Neurosciences Inc scale operations efficientlyJuly 2025 Selloffs & Expert Curated Trade Setup Alerts - baoquankhu1.vn
JUNS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026 - mydailyrecord.com
Parkinson’s trial and Nugevia revenue put Jupiter Neurosciences on BIO stage - Stock Titan
JUNS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Jupiter Neurosciences Receives Nasdaq Deficiency Notices, Faces Delisting - TipRanks
Jupiter Neurosciences Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Jupiter Neurosciences (JUNS) faces Nasdaq bid price and $35M value shortfall - Stock Titan
Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago - BioSpace
Chipmakers Recap: Does Sun Life Financial Inc stock have upside surprise potentialWeekly Trade Analysis & Consistent Return Strategy Ideas - baoquankhu1.vn
Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution - Delawareonline.com
Yorkville defers $6M to 2026 as Jupiter pushes Nugevia sales, Parkinson’s program - Stock Titan
JUNSJUPITER NEUROSCIENCES, INC. Latest Stock News & Market Updates - Stock Titan
Aug PostEarnings: How sensitive is HSTM to inflationTrade Volume Summary & Low Drawdown Investment Strategies - baoquankhu1.vn
Jupiter Neurosciences Amends Yorkville Financing Agreement Terms - TipRanks
Can Jupiter Neurosciences Inc. stock attract ESG capital inflowsMarket Rally & AI Forecasted Entry and Exit Points - mfd.ru
What is the earnings history of Jupiter Neurosciences Inc.Trade Entry Report & Weekly Watchlist for Consistent Profits - mfd.ru
Jupiter Neuroscience and ANNIKA Women’s All Pro Tour Announce Multi-Year Partnership - The Golf Wire
Can Jupiter Neurosciences Inc reach resistance levels soon2025 Dividend Review & Low Risk High Win Rate Picks - baoquankhu1.vn
Big Picture: What is the next catalyst for Jupiter Neurosciences Inc.July 2025 Drop Watch & Reliable Breakout Stock Forecasts - mfd.ru
Aug Wrap: Can Jupiter Neurosciences Inc. stock attract ESG capital inflowsInsider Selling & Long-Term Growth Plans - mfd.ru
Analyst Upgrade: Should I average down on PTPI stock2025 Trade Ideas & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Jupiter Neurosciences Selected as B2i Digital Featured Company - The Progress Index
Can Jupiter Neurosciences Inc. reach all time highs this year2025 Retail Activity & Growth Oriented Trading Recommendations - mfd.ru
Jupiter Neurosciences Selected as B2i Digital Featured Company Amid Parkinson's Trial and Consumer Brand Expansion - citybuzz -
Signal Recap: What analysts say about Jupiter Neurosciences Inc stockWeekly Investment Recap & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Jupiter Neurosciences Selected as B2i Digital Featured Company | Corporate - EQS News
Will Jupiter Neurosciences Inc. stock attract more institutional investors2025 Risk Factors & High Accuracy Swing Trade Signals - mfd.ru
Travel Stocks: Is Jupiter Neurosciences Inc currently under institutional pressureTrade Entry Report & AI Powered Market Entry Ideas - baoquankhu1.vn
Aug Analyst Calls: Is Jupiter Neurosciences Inc in a long term uptrendJuly 2025 Retail & Trade Opportunity Analysis Reports - baoquankhu1.vn
Dow Update: Will Cineverse Corp outperform tech stocksM&A Rumor & Weekly High Return Stock Forecasts - baoquankhu1.vn
Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users - The Desert Sun
Aug Reactions: Will Whitehawk Therapeutics Inc outperform tech stocks2025 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Gains Recap: Does Verde Clean Fuels Inc. have strong EBITDA marginsMarket Weekly Review & AI Forecasted Stock Moves - baoquankhu1.vn
Jupiter Neurosciences launches support initiative for GLP-1 users By Investing.com - Investing.com Nigeria
Jupiter Neurosciences Expands Nugevia™ Addressable Market With Focus On GLP-1 Users - Tampa Free Press
Portfolio Recap: What analysts say about ALCY stockCPI Data & Community Verified Watchlist Alerts - baoquankhu1.vn
Jupiter Neurosciences Expands Nugevia Addressable Market with Focus on GLP-1 Users - marketscreener.com
Jupiter Neurosciences launches support initiative for GLP-1 users - Investing.com
0.99%
3.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):